609 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by King Luther Capital Management Corp

King Luther Capital Management Corp purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 609 shares of the company’s stock, valued at approximately $248,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Cornerstone Advisors LLC raised its position in HCA Healthcare by 4.4% in the 3rd quarter. Cornerstone Advisors LLC now owns 14,300 shares of the company’s stock worth $5,812,000 after purchasing an additional 600 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in HCA Healthcare by 2.4% in the third quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock valued at $623,000 after acquiring an additional 36 shares during the last quarter. Advisors Asset Management Inc. lifted its position in HCA Healthcare by 28.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 4,030 shares of the company’s stock valued at $1,638,000 after purchasing an additional 892 shares during the period. Connor Clark & Lunn Investment Management Ltd. grew its position in shares of HCA Healthcare by 124.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 42,527 shares of the company’s stock worth $17,284,000 after buying an additional 23,553 shares during the period. Finally, Prospera Private Wealth LLC bought a new position in HCA Healthcare in the third quarter valued at approximately $133,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Morgan Stanley assumed coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. TD Cowen lowered their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Wells Fargo & Company lifted their target price on HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 6th. Six research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Stock Down 2.2 %

Shares of HCA stock opened at $324.93 on Monday. The firm has a market capitalization of $82.30 billion, a P/E ratio of 14.59, a PEG ratio of 1.28 and a beta of 1.68. The firm’s fifty day moving average price is $379.40 and its two-hundred day moving average price is $358.70. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 1 year low of $245.84 and a 1 year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. HCA Healthcare’s dividend payout ratio is 11.85%.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.